Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.0B | 6.4B | 6.2B | 6.3B |
Cost of revenue | 4.4B | 3.9B | 3.8B | 3.9B |
Gross profit | 2.6B | 2.4B | 2.4B | 2.4B |
Operating expense | ||||
Research & development | 192M | 198M | 201M | 207M |
Selling general and admin | 1.1B | 1.0B | 1.0B | 1.0B |
Other operating expenses | — | — | — | — |
Operating income | 1.3B | 1.2B | 1.2B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 71M | 33M | 42M | 29M |
Other income expense | 1M | 9M | -16M | 22M |
Pretax income | 1.2B | 1.2B | 1.2B | 1.2B |
Tax provision | 203M | 212M | 195M | 193M |
Net income | 982M | 965M | 971M | 1.0B |
Basic EPS | 2.5 | 2.5 | 2.5 | 2.5 |
Diluted EPS | 2.5 | 2.5 | 2.5 | 2.5 |
Basic average shares | 390.3M | 392.2M | 394.1M | 397.1M |
Diluted average shares | 391.4M | 393.6M | 396M | 398.9M |
EBITDA | 1.5B | 1.4B | 1.4B | 1.5B |
Net income from continuing op. | 982M | 965M | 971M | 1.0B |
Minority interests | -1M | -1M | 0 | -1M |
Preferred stock dividends | — | — | — | — |